Subpart H—Payment for End-Stage Renal Disease (ESRD) Services
Sections
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.
-
413.170
§ 413.170 Scope. -
413.171
§ 413.171 Definitions. -
413.172
§ 413.172 Principles of prospective payment. -
413.174
§ 413.174 Prospective rates for hospital-based and independent ESRD facilities. -
413.176
§ 413.176 Amount of payments. -
413.177
§ 413.177 Quality incentive program payment. -
413.178
§ 413.178 ESRD quality incentive program. -
413.180
§ 413.180 Procedures for requesting exceptions to payment rates. -
413.182
§ 413.182 Criteria for approval of exception requests. -
413.184
§ 413.184 Payment exception: Pediatric patient mix. -
413.186
§ 413.186 Payment exception: Self-dialysis training costs in pediatric facilities. -
413.194
§ 413.194 Appeals. -
413.195
§ 413.195 Limitation on Review. -
413.196
§ 413.196 Notification of changes in rate-setting methodologies and payment rates. -
413.198
§ 413.198 Recordkeeping and cost reporting requirements for outpatient maintenance dialysis. -
413.200
§ 413.200 [Reserved] -
413.202
§ 413.202 Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries. -
413.203
§ 413.203 Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries. -
413.210
§ 413.210 Conditions for payment under the end-stage renal disease (ESRD) prospective payment system. -
413.215
§ 413.215 Basis of payment. -
413.217
§ 413.217 Items and services included in the ESRD prospective payment system. -
413.220
§ 413.220 Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011. -
413.230
§ 413.230 Determining the per treatment payment amount. -
413.231
§ 413.231 Adjustment for wages. -
413.232
§ 413.232 Low-volume adjustment. -
413.233
§ 413.233 Additional facility-level adjustments. -
413.234
§ 413.234 Drug designation process. -
413.235
§ 413.235 Patient-level adjustments. -
413.236
§ 413.236 Transitional add-on payment adjustment for new and innovative equipment and supplies. -
413.237
§ 413.237 Outliers. -
413.239
§ 413.239 Transition period. -
413.241
§ 413.241 Pharmacy arrangements.